Article
Laser system yields high rate of patient satisfaction in study
Author(s):
Rochester, NY-The Technolas 217 Z Zyoptix Personalized Vision Correction system (Bausch & Lomb) was approved by the FDA for use in the United States last month (see related news on Page 1). About 99% of patients expressed extreme satisfaction or satisfaction with the visual results afforded them by the system, which may increase patient interest in refractive surgery.
Related Videos
Related Content
Published: October 12th 2024 | Updated: October 11th 2024
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial
